Literature DB >> 21247734

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).

Gordon H Guyatt1, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter, Susan L Norris, John W Williams, David Atkins, Joerg Meerpohl, Holger J Schünemann.   

Abstract

In the GRADE approach, randomized trials start as high-quality evidence and observational studies as low-quality evidence, but both can be rated down if most of the relevant evidence comes from studies that suffer from a high risk of bias. Well-established limitations of randomized trials include failure to conceal allocation, failure to blind, loss to follow-up, and failure to appropriately consider the intention-to-treat principle. More recently recognized limitations include stopping early for apparent benefit and selective reporting of outcomes according to the results. Key limitations of observational studies include use of inappropriate controls and failure to adequately adjust for prognostic imbalance. Risk of bias may vary across outcomes (e.g., loss to follow-up may be far less for all-cause mortality than for quality of life), a consideration that many systematic reviews ignore. In deciding whether to rate down for risk of bias--whether for randomized trials or observational studies--authors should not take an approach that averages across studies. Rather, for any individual outcome, when there are some studies with a high risk, and some with a low risk of bias, they should consider including only the studies with a lower risk of bias.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21247734     DOI: 10.1016/j.jclinepi.2010.07.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  700 in total

Review 1.  Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis.

Authors:  Shaun Coughlin; Lee Roth; Giovanna Lurati; Markus Faulhaber
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

2.  Marked variation in malignant transformation rates of oral leukoplakia.

Authors:  Aisling Anderson; Nurul Ishak
Journal:  Evid Based Dent       Date:  2015-12

3.  The Practice Guidelines for Primary Care of Acute Abdomen 2015.

Authors:  Toshihiko Mayumi; Masahiro Yoshida; Susumu Tazuma; Akira Furukawa; Osamu Nishii; Kunihiro Shigematsu; Takeo Azuhata; Atsuo Itakura; Seiji Kamei; Hiroshi Kondo; Shigenobu Maeda; Hiroshi Mihara; Masafumi Mizooka; Toshihiko Nishidate; Hideaki Obara; Norio Sato; Yuichi Takayama; Tomoyuki Tsujikawa; Tomoyuki Fujii; Tetsuro Miyata; Izumi Maruyama; Hiroshi Honda; Koichi Hirata
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 4.  Dressings and topical agents for treating pressure ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Marta O Soares; Nikki Stubbs; Gill Norman
Journal:  Cochrane Database Syst Rev       Date:  2017-06-22

Review 5.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

Review 6.  Behavior modification techniques used to prevent gestational diabetes: a systematic review of the literature.

Authors:  Helen Skouteris; Heather Morris; Cate Nagle; Alison Nankervis
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 7.  Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Authors:  Glen S Hazlewood; Cheryl Barnabe; George Tomlinson; Deborah Marshall; Daniel J A Devoe; Claire Bombardier
Journal:  Cochrane Database Syst Rev       Date:  2016-08-29

8.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

9.  The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review.

Authors:  Nico Gagelmann; Nicolaus Kröger
Journal:  Ann Hematol       Date:  2020-10-29       Impact factor: 3.673

Review 10.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.